Evidence map›Paper›PMID 40062260›Full record

ArticlePeerJ. Computer science2025

Predicting amyloid proteins using attention-based long short-term memory.

Zhuowen Li

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Zhuowen LiPunan Branch of Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is one of the genetically inherited neurodegenerative disorders that mostly occur when people get old. It can be recognized by severe memory impairment in the late stage, affecting cognitive function and general daily living. Reliable evidence confirms that the enhanced symptoms of AD are linked to the accumulation of amyloid proteins. The dense population of amyloid proteins forms insoluble fibrillar structures, causing significant pathological impacts in various tissues. Understanding amyloid protein's mechanisms and identifying them at an early stage plays an essential role in treating AD as well as prevalent amyloid-related diseases. Recently, although several machine learning methods proposed for amyloid protein identification have shown promising results, most of them have not yet fully exploited the sequence information of the amyloid proteins. In this study, we develop a computational model for

Indexed as

AlzheimerAmyloidAttentionDeep learningLSTMTransformers

Identifiers

PMID40062260
PMCPMC11888867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.